Damian A. Laber

A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma

Jonathan E. Rosenberg, Richard Bambury, Eliezer M. Van Allen et al. · Investigational New Drugs · 2013 · 411 citations · Full text

Medicine, Cancer Biology, Oncology +14

Clinical Efficacy and Toxicity of Anti-EGFR Therapy in Common Cancers

Amir Harandi, Aisha Zaidi, Abigail Stocker et al. · Journal of Oncology · 2009 · 114 citations · Full text

Medicine, Oncology, Pharmacology +16

Clinical spectrum of myelophthisis in cancer patients

Stephen N. Makoni, Damian A. Laber · American Journal of Hematology · 2004 · 51 citations · Full text

Medicine, Hematology, Oncology +17

Mobilization of Hematopoietic Progenitor Cells by Yeast-Derived<i>β</i>-Glucan Requires Activation of Matrix Metalloproteinase-9

Daniel Cramer, Stephanie A. Wagner, Bing Li et al. · Stem Cells · 2008 · 38 citations · Full text

Life Sciences, Hematology, Immunology +13

Update on the first phase I study of AGRO100 in advanced cancer

Damian A. Laber, Vivek R. Sharma, L. Bhupalam et al. · Journal of Clinical Oncology · 2005 · 35 citations

Pharmacy, Pharmacokinetics, Pharmacology +16